| Address |
235, Route Du Fleuve Ouest Ste-Luce, G0K 1P0 Canada |
|
| Address type | Registered Office Address | |
| Address province | Quebec |
| Corporation ID | 7144971 | |
| Business number | 813879020 | |
| Status | Active | |
| ACT | Canada Business Corporations Act | |
| Anniversary date | 03/24/2009 | |
| Last annual filing | 2026 | |
| Data verified | 10/31/2026 |
| Name | Effective date | Type | Current |
|---|---|---|---|
| Samuel C. Fortin Pharma inc. | 03/24/2009 | Corporate Name | true |
last updated: 2026-10-30
1 federal grant and contribution in 2018 with a total value of $45,250.
| Start date | Department and program | Value |
|---|---|---|
| 12/10/2018 |
National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) ARP - Increased omega-3 monoglyceride inflammation resolution activity The biological activity of omega-3 requires selective oxidation by lipoxygenase enzymes. In order to increase the activity of omega-3 monoglycerides, we want to premetabolize them with the help of a plant enzyme. |
$45,250 |
Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.
| Date | Type | Section |
|---|---|---|
| 03/24/2009 | Incorporation |
| Meeting date | Type of corporation | Year of filing |
|---|---|---|
| 03/09/2017 | Non-distributing corporation with 50 or fewer shareholders | 2017 |
| 02/09/2016 | Non-distributing corporation with 50 or fewer shareholders | 2016 |
| 02/26/2015 | Non-distributing corporation with 50 or fewer shareholders | 2015 |